ITAC

What this means for you

Not registered yet, but its 18 Oct 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98808648

Mark type

Stylized text

Filed

18 Oct 2024

Attorney of record

Norman P. Soloway

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; Pharmaceuticals for the treatment of cancer; Chemicopharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations for veterinary use for the treatment of cancer; Chemical preparations for pharmaceutical purposes for the treatment of cancer; Pharmaceutical preparations for human use for the treatment of cancer; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for veterinary purposes; Clinical diagnostic reagents; Diagnostic chemical reagents for medical use; Anticancer drugs; Compounds for treating cancer; Anti-cancer preparations; Anti-cancer preparations of chemical origin; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Chemotherapeutics; Antibodies for medical purposes; Antibody-drug conjugates for the treatment of cancer; Pharmaceutical preparations for immunotherapy
• Class 042 — Scientific and technological services: Pharmaceutical research services; Medical and pharmacological research services; Pharmaceutical product development; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Provision of research services in the field of toxicology, stem cell and medical research; Scientific research; Medical research; Biomedical research services; Research relating to biotechnology; Research on the subject of pharmaceuticals; Consultancy relating to research in the field of pharmacogenetics; Research and development in the pharmaceutical and biotechnology fields; Research and development in the field of diagnostic preparations; Research and development in the field of biotechnology; Research and development for the pharmaceutical industry; Research and development services in the field of antibody technology; Research and development services in the field of antibodies and antibody-drug conjugates; Laboratory services relating to the production of monoclonal antibodies and antibody-drug conjugates
• Class 044 — Medical, beauty and agricultural services: Pharmaceutical services, namely, pharmaceutical compounding services in the field of oncology; Pharmaceutical advice; Pharmaceutical services, namely, pharmaceutical compounding services; Consultancy and information services relating to pharmaceutical products; Providing healthcare information regarding cancer drugs and cancer treatment

Owner

• Heidelberg Pharma Research GmbH, Ladenburg, DE

Prosecution history

• 18 Jan 2026 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 17 Jul 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 17 Jul 2025 — LETTER OF SUSPENSION E-MAILED
• 17 Jul 2025 — SUSPENSION LETTER WRITTEN
• 03 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 03 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 03 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 24 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 24 Apr 2025 — NON-FINAL ACTION E-MAILED
• 24 Apr 2025 — NON-FINAL ACTION WRITTEN
• 22 Apr 2025 — ASSIGNED TO EXAMINER
• 21 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 18 Oct 2024 — NEW APPLICATION ENTERED